These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9014434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Symptomatic laterality and magnetic resonance imaging (MRI) of the putamen in striatonigral degeneration (SND)].
    Yanagihara C, Ichikawa K, Kageyama Y, Satou M, Hoshino M.
    Rinsho Shinkeigaku; 1994 Apr; 34(4):326-30. PubMed ID: 8026124
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).
    Puschban Z, Waldner R, Seppi K, Stefanova N, Humpel C, Scherfler C, Levivier M, Poewe W, Wenning GK.
    Exp Neurol; 2000 Jul; 164(1):166-75. PubMed ID: 10877927
    [Abstract] [Full Text] [Related]

  • 9. In vivo models of multiple system atrophy.
    Fernagut PO, Ghorayeb I, Diguet E, Tison F.
    Mov Disord; 2005 Aug; 20 Suppl 12():S57-63. PubMed ID: 16092092
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration.
    De Volder AG, Francart J, Laterre C, Dooms G, Bol A, Michel C, Goffinet AM.
    Ann Neurol; 1989 Aug; 26(2):239-47. PubMed ID: 2789014
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors.
    Churchyard A, Donnan GA, Hughes A, Howells DW, Woodhouse D, Wong JY, Kalnins RM, Mendelsohn FA, Paxinos G.
    Ann Neurol; 1993 Aug; 34(2):219-26. PubMed ID: 8338346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.
    Burn DJ, Rinne JO, Quinn NP, Lees AJ, Marsden CD, Brooks DJ.
    Brain; 1995 Aug; 118 ( Pt 4)():951-8. PubMed ID: 7655890
    [Abstract] [Full Text] [Related]

  • 19. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA, Rothblat DS, Joyce JN, Schneider JS.
    Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
    [Abstract] [Full Text] [Related]

  • 20. A novel grading scale for striatonigral degeneration (multiple system atrophy).
    Wenning GK, Seppi K, Tison F, Jellinger K.
    J Neural Transm (Vienna); 2002 Mar; 109(3):307-20. PubMed ID: 11956953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.